Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial /

Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin-kexin type 9 inhibition in such patients is undetermined.This pre-specif...

Full description

Saved in:
Bibliographic Details
Main Authors: Jukema J. Wouter
Szarek Michael
Zijlstra Laurien E.
de Silva H. Asita
Bhatt Deepak L.
Kollaborációs szervezet: ODYSSEY OUTCOMES Committees and Investigators
Merkely Béla Péter
Ungi Imre
Horváth Iván
Format: Article
Published: 2019
Series:JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 74 No. 9
Subjects:
doi:10.1016/j.jacc.2019.03.013

mtmt:32688478
Online Access:http://publicatio.bibl.u-szeged.hu/27008

Similar Items